Back to search results

Delirium Identification in Older Patients with Dementia in the Emergency Department

This study is looking at how well a special wrist device, the Empatica EmbracePlus, can help identify delirium in older patients with dementia who are in the Emergency Department (ED). Delirium is a serious medical condition where a person becomes confused and disoriented, and it's especially dangerous for those with Alzheimer's and other dementias. The study will enroll 60 participants aged 65 and older who have dementia and are expected to be in the ED or hospital for more than 4 hours. You would wear the Empatica EmbracePlus watch for up to 48 hours to collect information like heart rate and movement. Researchers will then see if this data correlates with whether you develop delirium. The goal is to find better ways to recognize delirium early.

Study design
This is an observational study with 60 participants. It is not testing a new treatment, but rather observing how a device works.
What's involved
You would wear a biosensor watch for up to 48 hours. Researchers will ask you (and a caregiver, if available) questions about the watch within 4-24 hours of placement, and again before discharge or over the phone.
Compensation
Not stated in the trial record.
Follow-up
Researchers will collect data for up to 48 hours, or until discharge if sooner. A final survey about acceptability will be completed before discharge or by phone afterwards.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06326424

Delirium Identification in Older Patients With Alzheimer's and Other Related Dementias In the Emergency Department

Recruiting
Not specifiedAges 65+Observational
Ohio State University
~60 participants
Updated 2025-04-03 on ClinicalTrials.gov
What's tested:Empatica EmbracePlus

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Proportion of participants who develop delirium
Measured over over the 48 hours of study participation

Conditions

Delirium
Dementia
Hospital Acquired Condition

Explore related trials

Alzheimer's DiseaseDeliriumDementia

Where it's being run

1 sites across 1 states
Ohio1

Study leadership

  • Edward Boyer, MD · STUDY_DIRECTOR · Ohio State University

Who to contact

Lauren Southerland, MD MPH
[email protected]
614-366-8375
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

adults patients 65+ years old with a known diagnosis of dementia or medical team highly suspects or confirms dementia this visit.
Emergency Department visit and/or hospitalization anticipated to last \>4 more hours from the time of enrollment.

Exclusion

Intubation/mechanical ventilation
Patients undergoing a procedure requiring sedation
Patients who cannot consent due to cognitive impairment and do not have a legally authorized representative or caregiver present.

What this trial measures

  • Proportion of participants who develop deliriumover the 48 hours of study participation

    The proportion of participants who develop delirium will be determined by one or more positive CAM-ICU 7 (Confusion Assessment Method- Intensive Care Unit 7) assessments during the study participation timeframe. The CAM-ICU 7 is a categorical test with 0 being no delirium and higher numbers signifying different levels of delirium.